header logo image


Page 1,399«..1020..1,3981,3991,4001,401..1,4101,420..»

Stem cell therapy using patient's own cells after heart attack does not enhance cardiac recovery

November 8th, 2012 6:42 am

Public release date: 6-Nov-2012 [ | E-mail | Share ]

Contact: Steve Goodyear sgoodyear@mhif.org 952-807-8365 Minneapolis Heart Institute Foundation

MINNEAPOLIS, MN November 6, 2012 Administering autologous stem cells obtained from bone marrow either 3 or 7 days following a heart attack did not improve heart function six months later, reports a new clinical trial supported by the National Institutes of Health. The results of this trial, called TIME (Transplantation In Myocardial Infarction Evaluation), were presented by Jay Traverse, MD of the Minneapolis Heart Institute Foundation Tuesday, Nov. 6, at the 2012 Scientific Sessions of the American Heart Association in Los Angeles.

The results of this trial mirror a previous, related study (LateTIME) which found that autologous bone marrow stem cell therapy given 2-3 weeks after a heart attack did not improve cardiac recovery. Both TIME and LateTIME were carried out by the Cardiovascular Cell Therapy Research Network (CCTRN), sponsored by the NIH's National Heart, Lung, and Blood Institute.

"The data presented by TIME do much to advance stem cell therapy research," said Jay Traverse, MD of the Minneapolis Heart Institute Foundation and Principal Investigator of this study. "While this study did not provide a demonstrated cardiac benefit after six months, we still learned a great deal. Together, TIME and Late TIME have shown that stem cell therapy is safe, and they have set a baseline in terms of quantity of stem cells, type of stem cells, and severity of heart attack."

TIME enrolled 120 volunteers (avg. age 57) between July 2008 and February 2011; the participants all had moderate to severe impairment in their left ventricle and had undergone coronary stent placement as treatment for the heart attack. The participants were randomly assigned to one of four groups: day 3 stem cell, day 3 placebo (inactive cells), day 7 stem cell, or day 7 placebo. The CCTRN researchers developed a method of processing and purifying the stem cells from the bone marrow of each volunteer to ensure everyone received a uniform dose (150 million stem cells).

Heart improvement was assessed six months after stem cell therapy by measuring the percentage of blood that gets pumped out of the left ventricle during each contraction (left-ventricular ejection fraction, or LVEF). The study found no significant differences between the change in LVEF readings at the six month follow-up in either the Day 3 or Day 7 stem cell groups compared with placebo or with each other; every group showed about a 3 percent improvement in LVEF. However, the researchers found that younger patients randomized to Day 7 had greater improvement in their LVEF compared to their placebo counterparts

"The lack of six-month improvement seen for TIME and, prior to that, LateTIME, does not mean stem cell therapy is not a viable post-heart attack strategy," said Traverse. "Because we have this data we can start to address some parameters; for example this therapy may work better in younger people, or maybe we need to use cells from healthy volunteers (allogeneic) since their cells may provide greater therapeutic benefit. There will also be upcoming studies using novel cell types which we look forward to using in future clinical trials."

###

For further information see:

More:
Stem cell therapy using patient's own cells after heart attack does not enhance cardiac recovery

Read More...

Studies On Stem Cell Therapy After Heart Attack Show Mixed Results

November 8th, 2012 6:42 am

April Flowers for redOrbit.com Your Universe Online

Conflicting studies were highlighted at this years American Heart Association Scientific Sessions meeting concerning stem cell therapy for heart attack patients.

The first study, from the University of Louisville and Brigham and Womens Hospital, reported holy grail results for a Phase I clinical trial: marked sustained improvement in all patients with zero adverse effects.

Roberto Bolli, M.D., of the University of Louisville and Piero Anversa, M.D., of Brigham and Womens Hospital presented data from their groundbreaking research in the use of autologous adult stem cells with patients who had previous heart attacks in a Late-Breaking Clinical Trial session.

The researchers report that all patients receiving the stem cell therapy showed improved heart function after two years, with an overall 12.9 absolute unit increase in left ventricular ejection fraction (LVEF). LVEF is a standard measure of heart function that shows the amount of blood ejected from the left ventricle during a heartbeat. They saw no adverse effects from the therapy. In fact, nine patients showed evidence of myocardial regeneration new tissue replacing formerly dead tissue killed by heart attack in MRI scans.

The trial shows the feasibility of isolating and expanding autologous stem cells from virtually every patient, said Bolli, who is the Jewish Hospital Heart and Lung Institute Distinguished Chair in Cardiology and director of the Institute for Molecular Cardiology in the Department of Medicine at UofL. The results suggest that this therapy has a potent, beneficial effect on cardiac function that warrants further study.

In all patients, cells with high regenerative reserve were obtained and employed therapeutically, said Anversa, professor of Anesthesia and Medicine at Brigham and Womens Hospital and Harvard Medical School. Our efforts to carefully characterize the phenotype and growth properties of the cardiac stem cells may have contributed to these initial positive results.

The Stem Cell Infusion in Patients with Ischemic CardiOmyopathy, or SCIPIO, trial was a randomized open-label trial of cardiac stem cells (CSCs) in patients who were diagnosed with heart failure following a myocardial infarction and had a LVEF of 40 percent or lower. A normal LVEF reading is 50 percent or higher.

The CSCs, referred to as c-kit positive cells because they express the c-kit protein on their surface, were harvested from 33 patients during coronary artery bypass surgery. The stem cells were then purified and processed so that they could multiply, and once an adequate number was produced about one million for each patient they were reintroduced into the region of the patients heart that suffered scarring during the heart attack.

At four months after infusion, the researchers report that LVEF increased from 29 percent to 36 percent for 200 patients. On average, the 13 control patients who did not receive a CSC infusion showed any improvement.

More:
Studies On Stem Cell Therapy After Heart Attack Show Mixed Results

Read More...

FAQ-10 of 19: Can Stem Cells Cause Cancer From Stem Cell Therapy? – Video

November 6th, 2012 5:44 pm


FAQ-10 of 19: Can Stem Cells Cause Cancer From Stem Cell Therapy?
youtu.be People ask us if stem cell therapy can CAUSE cancer, and they are wise to be wary, but stem cell therapy has been proving effective AGAINST cancer, and has not cause any known cases of cancer to-date. For more personalized information, visit StemCell-Asia.info now.From:Karridine1Views:1 0ratingsTime:01:06More inPeople Blogs

Read this article:
FAQ-10 of 19: Can Stem Cells Cause Cancer From Stem Cell Therapy? - Video

Read More...

FAQ-11 of 19: For Stem Cell Therapy, Why Thailand’s Licensed Stem Cell Treatments? – Video

November 6th, 2012 5:44 pm


FAQ-11 of 19: For Stem Cell Therapy, Why Thailand #39;s Licensed Stem Cell Treatments?
youtu.be You may wonder why coming to Thailand is a better investment of time, energy and resources, so here are some answers. For more personalized information as to how your condition might respond to stem cell therapy, go to the Apply Now page and send in copies of your medical records with an Application for Consideration. StemCell-Asia.infoFrom:Karridine1Views:1 0ratingsTime:01:16More inPeople Blogs

Read the original post:
FAQ-11 of 19: For Stem Cell Therapy, Why Thailand's Licensed Stem Cell Treatments? - Video

Read More...

FAQ-14 of 19: Do We Provide a Guarantee for Stem Cell Therapy? – Video

November 6th, 2012 5:44 pm


FAQ-14 of 19: Do We Provide a Guarantee for Stem Cell Therapy?
youtu.be This video addresses the ethical, practical aspects of a #39;guarantee #39; for stem cell therapy or stem cell treatments. For more detailed information concerning guarantees, stem cell therapy and your particular problem, visit bit.ly today.From:Karridine1Views:4 0ratingsTime:01:15More inPeople Blogs

Read the original:
FAQ-14 of 19: Do We Provide a Guarantee for Stem Cell Therapy? - Video

Read More...

Muscular Dystrophy Before and After Stem Cell Therapy – Video

November 6th, 2012 5:44 pm


Muscular Dystrophy Before and After Stem Cell Therapy
He took stem cell therapy at NeuroGen. Previously when he was climbing stairs, he was widening steps and climbing stairs. And he was taking more time, now he is taking less time. Climb stairs straight. Previously during sit to stand, he was taking support of hands and was coming up, but now he is not taking support. Previously when he was sitting on floor, he was facing in coming up and facing problem in walking few steps. But after stem cell therapy he can walk normally now. Now changes are seen. Stem Cell Treatment done at Neurogen ,Brain Spine Institute, Surana Sethia Hospital and Research Centre, Suman Nagar, Sion-Trombay Road, Chembur,Mumbai-71. Website -- http://www.neurogen.in http://www.stemcellsmumbai.com Tel: - +91 9920 200400, 022-25283706From:neurogenbsiViews:0 0ratingsTime:00:37More inScience Technology

Read more:
Muscular Dystrophy Before and After Stem Cell Therapy - Video

Read More...

Lysosomal Storage Disorders – Video

November 6th, 2012 5:44 pm


Lysosomal Storage Disorders
ll4.me Lysosomal Storage Disorders From Lysosomes to Storage Diseases and Back: A Personal Reminiscence.- Lysosomal Biogenesis and Disease.- The Concept of Treatment in Lysosomal Storage Diseases.- Complex Lipid Catabolism.- Retroviral Vectors for Gene Therapy.- Adenovirus in Gene Therapy.- Setting Back the Clock: Adenoviral-Mediated Gene Therapy for Lysosomal Storage Disorders.- Adeno-Associated Viral-Mediated Gene Therapy of Lysosomal Storage Disorders.- Herpes Simplex Virus Vectors for Gene Therapy of Lysomal Storage Disorders.- Gene Therapy of Lysosomal Storage Disorders by Lentiviral Vectors.- Substrate Reduction Therapy.- Newborn Screening for Lysosomal Storage Disorders.- Genetic Counseling for Lysosomal Storage Diseases.- Neural Stem Cell Therapy in Lysosomal Storage Disorders.- The GM1 Gangliosidoses.- The GM2 Gangliosidoses.- Acid Sphingomyelinase-Deficient Niemann-Pick Disease.- Krabbe Disease (Globoid Cell Leukodystrophy).- Metachromatic Leukodystrophy.- Fabry Disease.- Gaucher Disease: Review and Perspectives on Treatment.- Therapeutic Goals in the Treatment of Gaucher Disease.- The Neuronal Ceroid Lipofuscinoses: Clinical Features and Molecular Basis of Disease.- Mucopolysaccharidosis I.- Mucopolysaccharidosis II.- Sanfilippo Syndrome: Clinical Genetic Diagnosis and Therapies.- Mucopolysaccharidosis IV (Morquio Syndrome; MPS IV).- Mucopolysaccharidosis Type VI (MPS VI, Maroteaux-Lamy Syndrome).- Mucopolysaccharidosis Type VII (Sly Disease): Clinical, Genetic ...From:davidbrown9865Views:0 0ratingsTime:00:13More inPeople Blogs

Originally posted here:
Lysosomal Storage Disorders - Video

Read More...

The Patients of Angeles Health International – Video

November 6th, 2012 5:44 pm


The Patients of Angeles Health International
What our patients have to say about their experiences at Angeles Health International. All patients were treated for different conditions, in separate departments throughout our facilities. Angeles Health International offer cutting edge care, procedures and treatment in the following areas: Weight Loss Surgery - http://www.weightlossmex.com Stem Cell Therapy - http://www.stemcellmx.com Multiple Sclerosis Treatment - http://www.ccsvi.mx Effective Chemotherapy-free Cancer Treatment - http://www.cancertreatmentmx.com Visit the Angeles Health International website here: http://www.angeleshealth.com There are a team of healthcare professionals waiting to hear from you. Contact Angeles Health International toll free on: 1.866.668.9263From:AngelesHealthViews:5 0ratingsTime:03:06More inScience Technology

Original post:
The Patients of Angeles Health International - Video

Read More...

Stem Cell Malaysia | Stem Cell Therapy – Video

November 6th, 2012 5:44 pm


Stem Cell Malaysia | Stem Cell Therapy
stemcellmalaysia.com Stem Cell Malaysia shares with you actual user experience on stem cell therapy. Stem Cell Malaysia also provides useful information on stem cells, stem cell therapy, stem cell research and stem cell newsFrom:stemcells2012Views:102 4ratingsTime:03:17More inHowto Style

Read this article:
Stem Cell Malaysia | Stem Cell Therapy - Video

Read More...

Stem Cells Doctor in Mexico Shares his Expertise – Video

November 6th, 2012 5:44 pm


Stem Cells Doctor in Mexico Shares his Expertise
http://www.mexicohealth.com The video shows a stem cells doctor in Mexico discussing various procedures he specializes in, which notably are multiple sclerosis, brain degenerative disorders, and eye sight rectification. This stem cell specialist has treated over forty patients using cutting edge stem cell therapies. Despite cynical attitudes from different quarters, this doctor represents the vanguard for stem cell treatments for progressively degenerative conditions. To read the transcript and to get a free quote from stem cells doctor in Mexico. Click the link above. Related Searches: Stem Cell Therapy Doctors Mexico, stem cell treatment glaucoma mexico, stem cell therapy brain disorders mexico, stem cell therapy brain injury mexico, stem cell treatment spinal cord MX,From:mexicohealthViews:3 0ratingsTime:04:05More inPeople Blogs

Original post:
Stem Cells Doctor in Mexico Shares his Expertise - Video

Read More...

Stem Cells Treatment in Mexico – Reports You’ll Need – Video

November 6th, 2012 5:44 pm


Stem Cells Treatment in Mexico - Reports You #39;ll Need
http://www.mexicohealth.com The video shows a top stem cell specialist emphasizing the importance of reports and records in devising a sure shot stem cell treatment. Mexico is going where others have feared to tread by investing heavily in stem cell research and development. Not all conditions are curable using stem cells. Some even require a certain degree of faith in your doctor. This doctor has helped more than 40 patients to get up on their feet. Communication is the key, as this doctor points out. If you #39;re mulling over getting a stem cell treatment in Mexico, for yourself or somebody you know, always remember to carry exhaustive reports. To get a free quote, click the link above. Related Searches: stem cell therapy specialists mexico, Stem Cell Treatment for Multiple Sclerosis Mexico, Stem Cell Therapy in Mexico for Chronic Heart Failure, Adult Stem Cell Treatment in Mexico, Stem Cell Therapy for Diabetes Mexico, stem cell treatment for brain damage Mexico, Stem Cell Treatment for Neurodegenerative Conditions mexico, Stem Cell Treatment for Eye Diseases Mexico, Stem Cell Treatment for Heart Conditions Mexico, Stem Cell Therapy for Brain Injury Mexico,From:mexicohealthViews:3 0ratingsTime:02:08More inPeople Blogs

Read this article:
Stem Cells Treatment in Mexico - Reports You'll Need - Video

Read More...

Autologous and Adult Stem Cells Transplant in Mexico – Video

November 6th, 2012 5:44 pm


Autologous and Adult Stem Cells Transplant in Mexico
http://www.mexicohealth.com The video shows a top stem cell specialist in Mexico explaining why autologous stem cell treatment is a better choice than adult stem cell transplant. The doctor goes on to caution about risks of reaction in case of adult stem cells transplant. In some cases, the reaction could kill. Autologous, on the other hand, is a safe proposition. The doctor has been in the profession since 1978 and has treated over 40 patients with acute degenerative disorders like, multiple sclerosis. To read the transcript of the video about autologous and adult stem cell transplant in Mexico, click the link above. Related Searches: Autologous stem cell transplant mexico, Hematopoietic stem cell transplantation mexico, Stem Cell Transplantation in Adults mexico, Stem cell treatment ms mexico, stem cell treatment glaucoma mexico, stem cell therapy brain disorders mexico, stem cell therapy brain injury mexico, stem cell treatment spinal cord MX,From:mexicohealthViews:2 0ratingsTime:03:08More inPeople Blogs

Read more here:
Autologous and Adult Stem Cells Transplant in Mexico - Video

Read More...

Stem cell therapy may not improve recovery after heart attack

November 6th, 2012 5:44 pm

Washington, November 6 (ANI): Administering to patients stem cells derived from their own bone marrow either three or seven days after a heart attack is safe but does not improve heart function six months later, according to a clinical trial.

The results of the trial, called Transplantation In Myocardial Infarction Evaluation (TIME), mirror a previous, related study, LateTIME, which found that such cells (called autologous stem cells) given two to three weeks after a heart attack did not improve heart function.

Both TIME and LateTIME were conducted by the Cardiovascular Cell Therapy Research Network (CCTRN), sponsored by the NIH's National Heart, Lung, and Blood Institute.

"This study was extremely valuable even though it did not provide a demonstrated health benefit after six months," said Sonia Skarlatos, Ph.D., deputy director of NHLBI's Division of Cardiovascular Sciences and member of the CCTRN.

"Heart stem cell therapy research is still in its infancy, and results from early trials have varied greatly due to differences in the numbers of stem cells injected, the delivery methods used, and the compositions of the study populations. With TIME and LateTIME, we have established both safety and baseline results in two large studies that followed the same procedures for growing and then administering stem cells. This standard will inform the next steps in research on the use of stem cells to repair damaged hearts," she stated.

Fellow CCTRN member Jay Travese, M.D., of the Minneapolis Heart Institute added, "With this baseline now set, we can start to adjust some of the components of the protocol to grow and administer stem cell to find cases where the procedure may improve function."

"For example, this therapy may work better in different population groups, or we might need to use new cell types or new methods of delivery," he noted.

Skarlatos said that another advantage of the TIME study is that CCTRN is storing samples of the stem cells taken from the participants. Investigators can examine the relationship between people who showed significant improvement during the study and the characteristics of their stem cells. Such a comparison may offer insights on the cell traits that are associated with clinical improvement.

The findings will be presented at the American Heart Association (AHA) 2012 Scientific Sessions in Los Angeles and will appear concurrently in the Journal of the American Medical Association. (ANI)

Read more from the original source:
Stem cell therapy may not improve recovery after heart attack

Read More...

Cardiac Cell Therapy Phase III Trial to Treat Refractory Angina

November 6th, 2012 5:44 pm

RIO DE JANEIRO--(BUSINESS WIRE)--

CryopraxisTM/CellPraxis aims to start patient recruitment for its Phase III Refractory Angina Cell Therapy Brazilian arm clinical trial by the end of 2012 or early 2013. The phase IIA/B clinical trial study was completed in December 2011. These trials involved the use of a proprietary autologous stem cell formulation (MonocellTM) indicated for neoangiogeneses.

Safety and efficacy of this product was evaluated in patients with refractory angina, a no option disease condition, characterized by severe chest pain for which there is no efficient treatment available, says the President of both Companies, Eduardo Cruz.

ReACT, MonocellTMs derived product, showed evidence of safety and efficacy in our initial clinical trials. All patients included in this trial were classified as Class IV Angina in CCSAC* (the most severe class of chest pain). In the first group of patients, whose data was published**, there was a progressive and sustained improvement in angina symptoms, with 87.5% of the patients completing the clinical trial with a CCSAC score of 0 or 1.

Angina symptom relief began as early as 3 months post procedure with continuing improvement through the 18th month, suggesting that angiogenesis began early, and that it kept evolving 18 months after the procedure. Objective evaluation of stress myocardium perfusion (scintigraphic analysis), after 1 year of follow-up, gave indications of complete myocardial reperfusion in 75% of the patients, says Dr. Nelson Hossne, Medical Director of CellPraxis. Our conclusion was ReACT's specific cell formulation, MonoCell, had a direct correlation to myocardial neoangiogeneses.

About CryopraxisTM (www.cryopraxis.com.br) and CellPraxis (www.cellpraxis.com)

Located at Bio-Rio Biotech Cluster (Rio de Janeiro, Brazil), CryopraxisTM is the pioneer and the largest bank of umbilical cord blood in Brazil and has been in operation since 2001, with approximately 25,000 customers. CellPraxis is a bioengineering company that invests in research projects involving stem cell therapy. Some of these projects are conducted in partnership with institutions like the Federal University of Rio de Janeiro, Federal University of So Paulo, the University of South Florida and Saneron CCEL Therapeutics, Inc. (a USA based biotechnology company dedicated to stem cell research).

Forward-Looking Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. The Company's actual results could differ materially from those anticipated in these forward- looking statements as a result of various factors. The Company's further development is highly dependent on future medical and research developments and market acceptance, which is outside its control.

See original here:
Cardiac Cell Therapy Phase III Trial to Treat Refractory Angina

Read More...

cord blood bank | Cheapest Cord Blood Banking – Video

November 6th, 2012 9:56 am


cord blood bank | Cheapest Cord Blood Banking
http://www.cordbloodrecommendation.com Close family limbs of the patron then have access to correct reaches if the require arises. It includes enrollment charges, collection, and storage for a minimum of one year. Cord blood banking is not new. These days cord blood is also collected for research purposes. This article is to help the reader understand the two types of stem cells, where they come from and what diseases are currently being treated using the research and data collected from stem cell study. What Is Cord Blood?Highly rich in stem cells, cord blood refers to the blood that remains in the placenta and umbilical cord just after delivery. ""Cord Blood Banking allows parents to collect their baby #39;s stem cells at birth and store long term for possible use in treating over 70 diseases. ""Do you suffer leukemia? It will be your good news then. Given his practically non-existent immune system, chemotherapy was not an option as it would have killed him. It goes without saying that a private cord blood bank offers assurances that a public cord blood bank cannot make. Their potential to grow into other cells is also being studied. Your transplant doctor knows your situation and can help you make choices about your treatment. The list of potential areas of use is almost endless. He was given a transplant in which the stem cells were taken from around 10 different donors. cordocentesis. The cord blood stem cells have created your baby and by preserving those stem cells, you areFrom:Implantes DentalesViews:0 0ratingsTime:01:13More inScience Technology

Link:
cord blood bank | Cheapest Cord Blood Banking - Video

Read More...

cord blood banking | 3 Reasons Why Price Shouldn’t Be the Deciding Factor When Choosing a Cord Blood – Video

November 6th, 2012 9:56 am


cord blood banking | 3 Reasons Why Price Shouldn #39;t Be the Deciding Factor When Choosing a Cord Blood
http://www.cordbloodrecommendation.com Finally, it is essential that your baby #39;s blood is saved in a bank that boasts of an appreciable history and its samples are used frequently for successful transplant operations. Cord blood banking is simply storage or preservation of stem cells. The stem cells can be thawed in the future and used to treat certain diseased for the baby or possible family members. Other prospective adverse effects contain blood loss from the puncture site, infection, drop in fetal heart rate, and premature rupture of membranes. Openly. Since children that come from the same mother and father share genetic material, this cord blood containing the stem cells can be used to treat all children in a family for these diseases, including leukemia and sickle cell anemia. This cord blood can be used to help patients such as Courtney, patients who are given a second chance at life due to a simple donation. But you can never go back if you change your mind and decide you really wanted to save it. The stem cells found in cord blood are proven to be precious when treating a child or sibling for potentially deadly diseases and medical disorders. The immune cells present in cord blood are less likely to attack the tissue of patient (graft vs. To obtain these stem cells, your doctor would extract blood from the umbilical cord when your baby is born. This is a one time charge and this gets the blood banking process going. Collecting the umbilical cord blood does not hurt ...From:myc0kyViews:0 0ratingsTime:01:13More inScience Technology

See the original post here:
cord blood banking | 3 Reasons Why Price Shouldn't Be the Deciding Factor When Choosing a Cord Blood - Video

Read More...

Prof Siddarthan Chandran – Stem cell research – Video

November 6th, 2012 9:56 am


Prof Siddarthan Chandran - Stem cell research
Professor Siddharthan Chandran is Director of the Euan MacDonald Centre for Motor Neurone Disease Research at the University of Edinburgh. Stem cells have heralded a revolution in research, offering genuine possibilities for the discovery and delivery of new treatments. Professor Chandran will explore the myths and hype surrounding stem cells and present the potential promise research in this area could bring to patients with neurodegenerative conditions. This lecture is part of the Medical Detectives, a series of public lectures that show how keen detective work is still essential for 21st century doctors: http://www.ed.ac.uk Recorded on 1 November 2012 in the Anatomy Lecture Theatre at the University of Edinburgh.From:EdinburghUniversityViews:1 3ratingsTime:56:05More inEducation

See the original post:
Prof Siddarthan Chandran - Stem cell research - Video

Read More...

Stem Cells In Development And Disease – Video

November 6th, 2012 9:56 am


Stem Cells In Development And Disease
ll4.me Stem Cells In Development And Disease EAN/ISBN : 9780080490939 Publisher(s): Elsevier Science Technology, Academic Press Format: ePub/PDF Author(s): Schatten, Gerald EAN/ISBN : 9780080490939 Publisher(s): Elsevier Science Technology, Academic Press Format: ePub/PDF Author(s): Schatten, GeraldFrom:lesbolles9865Views:0 0ratingsTime:00:19More inPeople Blogs

Link:
Stem Cells In Development And Disease - Video

Read More...

Cure for autism? – Video

November 6th, 2012 9:56 am


Cure for autism?
Autism is a national epidemic in the United States, with one out of every 88 children being diagnosed on the spectrum. Anna Kooiman sits down with an expert, who is leading a ground-breaking clinical trial that uses cord blood stem cells in the hopes of curing the disorderFrom:FoxNewsChannelViews:30 1ratingsTime:05:00More inNews Politics

Read more here:
Cure for autism? - Video

Read More...

Growth Hormone – Video

November 6th, 2012 9:56 am


Growth Hormone
ll4.me Growth Hormone Introduction.- Placenta and early embryonic development.- Experimental models.- Evolution, aging, life span.- Brain development.- Development of sensory organs.- Neuroplasticity and neuroprotection.- Reproductive tract.- Skeletal muscle.- Cardiovascular system-lung.- Hematopoiesis.- Pancreas development and glucose regulation.- IGF interaction with other trophic factors.- Cancer.- Human genetics of the GH-IGF-I axis.- Future perspectives-stem cells.- Index EAN/ISBN : 9780387262741 Publisher(s): Springer, Berlin, Springer US Discussed keywords: Wachstumshormon Format: ePub/PDF Author(s): Varela-Nieto, Isabel - Chowen, Julie A. Introduction.- Placenta and early embryonic development.- Experimental models.- Evolution, aging, life span.- Brain development.- Development of sensory organs.- Neuroplasticity and neuroprotection.-From:lamarpalmer654Views:0 0ratingsTime:00:14More inPeople Blogs

Here is the original post:
Growth Hormone - Video

Read More...

Page 1,399«..1020..1,3981,3991,4001,401..1,4101,420..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick